The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2 diabetes. Some of these treatments might help people lose even more weight than current forerunners like Novo Nordisk’s semaglutide—the active…
The World Health Organization is warning the public to stay away from counterfeit Ozempic, or “fauxzempic.” The agency has recently received reports of medication falsified to appear like the diabetes and off-label weight loss drug Ozempic in at least three countries, including the U.S.
Semaglutide, the active ingredient in popular diabetes and obesity drugs Ozempic and Wegovy, can also tweak people’s taste buds for the better, preliminary research suggests. Scientists found that women taking semaglutide improved their taste sensitivity, particularly to sweetness. The findings may illuminate another…
Pharmaceutical company Eli Lilly is making a plea to some of its customers: stop hoarding our weight loss drugs. In a new Oscar-themed commercial set to run on TV this weekend, the drugmaker is not-so-subtly telling people to stay away from its new blockbuster medications if they’re only looking to lose a few pounds.…
Wegovy and similar weight loss drugs may cause more side effects than currently recognized. The Food and Drug Administration is now looking into whether these new generation obesity drugs can trigger hair loss, suicide ideation, and food aspiration, based on adverse event reports linked to their use. These reports are…
